Oncology Institute, Inc. (TOI) Return on Invested Capital (2021 - 2022)
Oncology Institute's (TOI) quarterly Return on Invested Capital came in at 3.99% in Q3 2022, up 402.0% YoY from 0.8% in Q3 2021, and up 8.31% on a QoQ basis from 3.69% in Q2 2022.
Oncology Institute, Inc. (TOI) Return on Invested Capital (2021 - 2022) Analysis & Trends
Oncology Institute (TOI) has 2 years of Return on Invested Capital data on file, last reported at 3.99% in Q3 2022.
- Quarterly Return on Invested Capital rose 402.0% year-over-year to 3.99% in Q3 2022, while the trailing twelve-month figure through Sep 2022 was 3.99% (up 402.0% YoY) and the FY2021 annual result came in at 0.16%, changed N/A from the prior year.
- Return on Invested Capital grew to 3.99% in Q3 2022, from 3.69% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 3.99% in Q3 2022 to a low of 3.7% in Q1 2022.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 3.99% |
| Jun 30, 2022 | 3.69% |
| Mar 31, 2022 | -3.70% |
| Dec 31, 2021 | -0.16% |
| Sep 30, 2021 | -0.03% |
| Jun 30, 2021 | -0.02% |